Immunocore
@Immunocore
Followers
3K
Following
208
Media
685
Statuses
1K
A leading TCR biotechnology company focused on delivering first-in-class biological therapies. See our community guidelines: https://t.co/oOLfCWfVNO
UK & US
Joined July 2013
Today is #WorldMentalHealthDay and #WorldSightDay – two causes close to our heart. Regular eye check-ups can make a world of difference, as can looking after our mental health! #WeAreIMCR
0
2
4
Our #IT team is #hiring: if you have experience in infrastructure design, system admin and deployment, network and security management… get in touch! #WeAreIMCR #BiotechJobs
https://t.co/kM6Iqba6GC
0
0
0
What does it mean to have a fully integrated, ‘bench to bedside’ process? We asked Shahid Uddin, our Senior Director of Formulation Development & Stability. #LikeIMCR #manufacturing
0
0
0
We are pleased to be working with @TheCrick and @RoyalMarsdenNHS on a UK population-level study to better understand responses to #immunotherapy in cancer. #LikeIMCR #oncology
We're delighted to lead a new project with @RoyalMarsdenNHS to study responses to cancer immunotherapy. The platform has received £20m+ in public and industry investment and will involve thousands of people from across the UK receiving immunotherapy. 🔗 https://t.co/2uHtn1fc62
0
0
0
Join our wide-ranging #CMC function and support our supply chain as Associate Manufacturing & Outsourcing Specialist. #manufacturing #WeAreIMCR #biotechjobs #hiring
https://t.co/hcoU7rPYHw
0
0
0
In the 1720s, Onesimus described an early form of inoculation, laying the foundations for future smallpox vaccines. This #BlackHistoryMonth, we celebrate his influence and those of other brilliant black scientists. #WeAreIMCR
0
1
3
We end #OvarianCancerAwarenessMonth with a quiz. #IMCRSharing According to Globocan, what is the projected increase in the number of women diagnosed with ovarian cancer globally by 2050? Answer in the link:
0
0
0
If you have the expertise to navigate complex international IP landscapes and ensure our assets are well protected, we want you on board! Apply now! https://t.co/HS5UJL92Cv
#WeAreIMCR #hiring #innnovation #biotech
0
0
0
With our teams having grown to deliver our mission, we have moved into a new office in Maryland. Thank you to our previous landlords and we look forward to becoming part of the Rio Lakefront business community! #WeAreIMCR
0
0
1
Following a review of our social media strategy, we will close our X account next month. We want to thank each one of you for your support and engagement. You can follow us on LinkedIn @Immunocore and sign-up for updates on our website. https://t.co/NIJldDDa3C
#WeAreIMCR
0
0
0
Each year 324,000 women are diagnosed with #ovarian cancer. The disease is the 8th most common cancer and the most common cause of death from cancer in women, worldwide. #OvarianCancerAwarenessMonth #GCAM #WeAreIMCR @ocrahope Ref: https://t.co/oNqsp23OhN
0
0
0
A leader in advanced scientific research, our CTO, Annelise Vuidepot, is at the forefront of the latest advancements in TCR therapy. Hear her share insights and current progress in the field: https://t.co/z3F1MfXt3c
#IMCRSharing #immunotherapy
0
0
3
Join us as an expert advisor in #healthcare compliance and drive the continuous improvement of our #compliance program and ethical practices. Apply now! #WeAreIMCR #hiring
https://t.co/BFrwuP72W1
0
0
2
Did you know, a fifth of #ovarian cancers are caused by a genetic mutation? #OvarianCancerAwarenessMonth #GCAM #IMCRSharing @ocrahope
0
0
0
#ESMO24 was another great congress for new data and scientific exchange. See you again next year @myESMO! #IMCRSharing #ImmunoOncology
0
0
0
#ICYMI for #Investors and #Media: We shared Phase 1 data in ovarian cancer, and insights into the association of T cell fitness with ImmTAC clinical activity: https://t.co/dV7F9VoLiE
#OvarianCancerAwarenessMonth #GCAM
0
1
1
#News for #Investors and #Media: We will present new insights on the association between T cell fitness and clinical activity of ImmTAC therapies, in an oral session at #ESMO24 today. #immunotherapy
0
0
0
If you are at #ESMO24 and want to visualize how our ImmTAC technology works, check our new mechanism of action video on YouTube: https://t.co/CVzoSw8dj2
#immunotherapy #IMCRSharing #innovation
0
0
1
Step into the pioneering world of T cell receptor biotechnology, and help us help patients by joining our #clinical team. https://t.co/ceO20qr2aE
#BiotechJobs #WeAreIMCR
0
0
0